Three phase 99Tcm (V)DMSA scintigraphy in Paget's disease: an indicator of pamidronate effect.
The use of three phase 99Tcm (V)DMSA scintigraphy is reported in a patient with Paget's disease of bone before and after intravenous pamidronate therapy. It was a useful modality for estimating the activity of Pagetoid lesions and the therapeutic effect of pamidronate, from a different aspect to bone scintigraphy. Three phase 99Tcm (V)DMSA scintigraphy evaluates both the blood flow and the metabolic activity of Pagetoid bone.
Kobayashi
H
H
Department of Radiology and Nuclear Medicine, Kyoto University, Faculty of Medicine, Japan.
Shigeno
C
C
Sakahara
H
H
Yamamoto
T
T
Hosono
M
M
Fujimoto
R
R
Konishi
J
J
D000368:Aged; D000369:Aged, 80 and over; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D006811:Humerus / Q000000981:diagnostic imaging; D008297:Male; D010001:Osteitis Deformans / Q000000981:diagnostic imaging* / Q000188:drug therapy; D000077268:Pamidronate; D011877:Radionuclide Imaging; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D016896:Treatment Outcome
D004164:Diphosphonates; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D000077268:Pamidronate